Sinergismo do Licopeno e Outras Drogas Contra o Câncer: uma prospecção tecnológica

Autores

DOI:

https://doi.org/10.9771/cp.v15i3.42989

Palavras-chave:

Licopeno, Agentes Antineoplásicos, Sinergismo de Drogas.

Resumo

O presente trabalho tem como objetivo realizar um estudo prospectivo sobre a utilização do licopeno, com atividade antitumoral comprovada em literatura, em adição a outras drogas antitumorais no combate ao câncer. Para tanto, foram realizadas pesquisas nos bancos de dados de patentes como INPI, USPTO, Espacenet e WIPO, bem como em artigos científicos nas bases PubMed, Web of ScienceTM, Scopus e Scielo, com o uso de palavras-chave e de operadores boleanos específicos, utilizados no campo de busca relativo ao título ou ao resumo dos arquivos. Verificou-se um baixo número de documentos referentes à aplicação do licopeno contra o câncer e a inexistência de patentes explorando o potencial sinérgico com outras drogas. Além disso, nas bases de dados de artigos científicos e patentes, foram encontrados poucos arquivos relacionados com a atividade anticâncer do licopeno e seu efeito sinérgico, reforçando o caráter inovador das pesquisas que envolvem o uso desse carotenoide.

Downloads

Não há dados estatísticos.

Biografia do Autor

Antônio Kleiton de Sousa, Universidade Federal do Delta do Parnaíba

Graduando em Biomedicina pela Universidade Federal do Delta do Parnaíba.

Diva de Aguiar Magalhães, Universidade Federal do Delta do Parnaíba

Doutora em Biotecnologia pela Universidade Federal do Piauí em 2021.

Marcia Luana Gomes Perfeito, Universidade Federal do Delta do Parnaíba

Doutora em Biotecnologia pela Universidade Federal do Piauí em 2022.

Stefany Guimarães Sousa, Universidade Federal do Delta do Parnaíba

Mestre em Biotecnologia pela Universidade Federal do Piauí em 2017.

Referências

AGARWAL, S.; RAO, A.V. Tomato lycopene and its role in human health and chronic diseases. CMAJ, [s.l.], v. 163, n. 6, p. 739-744, 2000.

AKTEPE, O. H. et al. Lycopene sensitizes the cervical cancer cells to cisplatin via targeting nuclear factor- kappa B (NF-κB) pathway. Turk J Med Sci, [s.l.], v. 51, n. 1, p. 368-374, 2021.

AL-MALKI, A. L.; MOSELHY, S. S.; REFAI, M. Y. Synergistic effect of lycopene and tocopherol against oxidative stress and mammary tumorigenesis induced by 7,12-dimethyl[a]benzanthracene in female rats. Toxicol Ind Health, [s.l.], v. 28, n. 6, p. 542-548, 2012.

AMIR, H. et al. Lycopene and 1,25-dihydroxyvitamin D3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells. Nutr Cancer, [s.l.], v. 33, n. 1, p. 105-112, 1999.

BACANLI, M.; BAŞARAN, N.; BAŞARAN A. A. Lycopene: Is it Beneficial to Human Health as an Antioxidant? Turk J Pharm Sci, [s.l.], v. 14, n. 3, p. 311-318, 2017.

BARBER, N. J.; BARBER, J. Lycopene and prostate cancer. Prostate Cancer Prostatic Dis, [s.l.], v. 5, n. 1, p. 6-12, 2002.

BASU, A.; IMRHAN, V. Tomatoes versus lycopene in oxidative stress and carcinogenesis: conclusions from clinical trials. Eur. J. Clin. Nutr., [s.l.], v. 61, p. 295-303, 2007.

CHEN, D.; HUANG, C.; CHEN, Z. A review for the pharmacological effect of lycopene in central nervous system disorders. Biomed Pharmacothe, [s.l.], v. 111, p. 791-801, 2019.

CHEN, J. et al. The effect of lycopene on the PI3K/Akt signalling pathway in prostate cancer. Anticancer Agents Med Chem, [s.l.], v. 14, n. 6, p. 800-805, 2014.

GAJOWIK, A.; DOBRZYŃSKA, M. M. Lycopene - antioxidant with radioprotective and anticancer properties. A review. Rocz Panstw Zakl Hig, [s.l.], v. 65, n. 4, p. 263-271, 2014.

GIOVANNUCCI, E. A review of epidemiologic studies of tomatoes, lycopene, and prostate cancer. Exp Biol Med, [s.l.], v. 227, n. 10, p. 852-859, 2002.

HAN, H.; LIM, J.W.; KIM, H. Lycopene Inhibits Activation of Epidermal Growth Factor Receptor and Expression of Cyclooxygenase-2 in Gastric Cancer Cells. Nutrients, [s.l.], v. 11, n. 9, p. 2.113, 2019.

HEBER, D.; LU, Q.-Y. Overview of Mechanisms of Action of Lycopene. Experimental Biology and Medicine, [s.l.], v. 227, n. 10, p. 920-923, 2002.

HOLZAPFEL, N. P. et al. The potential role of lycopene for the prevention and therapy of prostate cancer: from molecular mechanisms to clinical evidence. Int J Mol Sci, [s.l.], v. 14, n. 7, p. 14.620-14.646, 2013.

JAIN, A. et al. Fabrication and functional attributes of lipidic nanoconstructs of lycopene: An innovative endeavour for enhanced cytotoxicity in MCF-7 breast cancer cells. Colloid surface B., [s.l.], v. 152, p. 482-491, 2017.

JÚNIOR, H. P. L.; BRUNELLI, M. J.; LEMOS, A. L. A. Licopeno: Diagn Tratamento, São Paulo, v. 16, n. 2, p. 71-74, 2011.

KELKEL, M. et al. Antioxidant and anti-proliferative properties of lycopene. Free Radic Res, v. 45, n. 8, p. 925-940, 2011.

KHACHIK, F. et al. Chemistry, distribution, and metabolism of tomato carotenoids and their impact on human health. Exp Biol Med, [s.l.], v. 227, n. 10, p.845-851, 2002.

LANGNER, E.; LEMIESZEK, M. K.; RZESKI, W. Lycopene, sulforaphane, quercetin, and curcumin applied together show improved antiproliferative potential in colon cancer cells in vitro. J Food Biochem, [s.l.], v. 43, n. 4, p.e12802, 2019.

LINNEWIEL-HERMONI, K. et al. The anti-cancer effects of carotenoids and other phytonutrients resides in their combined activity. Arch Biochem Biophys, [s.l.], v. 572, p. 28-35, 2015.

LIU, C.; RUSSELL, R. M.; WANG, X. D. Lycopene supplementation prevents smoke-induced changes in p53, p53 phosphorylation, cell proliferation, and apoptosis in the gastric mucosa of ferrets. J. Nutr., [s.l.], v. 136, n. 1, p. 106-111, 2006.

MACHADO, K. C. et al. Uso de marcadores moleculares na depressão: prospecção tecnológica. Revista GEINTEC, [s.l.], v. 4, n. 3, p. 1.008-1.016, 2014.

MATOS, H. R.; MASCIO, P. D.; MEDEIROS, M. H. Protective effect of lycopene on lipid peroxidation and oxidative DNA damage in cell culture. Arch Biochem Biophys, [s.l.], v. 383, n. 1, p. 56-59, 2000.

MORITZ, B.; TRAMONTE, V. L. C. Biodisponibilidade do licopeno. Rev. Nutr., [s.l.], v. 19, n. 2, p. 265-273, 2006.

MOSSINE, V. V.; CHOPRA, P.; MAWHINNEY, T. P. Interaction of Tomato Lycopene and Ketosamine against Rat Prostate Tumorigenesis. Cancer Research, [s.l.], v. 68, n. 11, p. 4.384-4.391, 2008.

NEWMAN, D. J.; CRAGG, G. M. Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. J Nat Prod, [s.l.], v. 83, n. 3, p. 770-803, 2020.

PALOZZA, P. et al. Lycopene prevents 7-ketocholesterol-induced oxidative stress, cell cycle arrest and apoptosis in human macrophages. J. Nutr. Biochem., [s.l.], v. 21, n. 1, p. 34-36, 2010.

PREET, R. et al. Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC. Carcinogenesis, [s.l.], v. 34, n. 2, p. 277-86, 2013.

RAHMANI, A. H. et al. Therapeutic implications of black seed and its constituent thymoquinone in the prevention of cancer through inactivation and activation of molecular pathways. Evid Based Complement Alternat Med, [s.l.], v. 2.014, p.724658, 2014.

RAHMANI, A. H.; ALY, S. M. Nigella sativa and its active constituents thymoquinone shows pivotal role in the diseases prevention and treatment. Asian J. Pharm. Clin. Res., [s.l.], v. 8, p. 48-53, 2015.

RANJAN, A. et al. Role of Phytochemicals in Cancer Prevention. Int. J. Mol. Sci., [s.l.], v. 20, n. 20, p. 4.981, 2019.

ROWLES, J. L. et al. Increased dietary and circulating lycopene are associated with reduced prostate cancer risk: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis, [s.l.], v. 20, n. 4, p. 361-377, 2017.

SIEGEL, R. L.; MILLER, K. D.; JEMAL, A. Cancer statistics 2019. CA Cancer J Clin, [s.l.], v. 69, n. 1, p. 7-34, 2019.

SONG, X. et al. Recent trends and advances in the epidemiology, synergism, and delivery system of lycopene as an anti-cancer agent. Semin Cancer Biol., [s.l.], v. 73, p. 331-346, 2021.

STAHL, W.; SIES, H. Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans. J. Nutr., [s.l.], v. 122, n. 11, p. 2161-2166, 1992.

TORRE, L. A. et al. Global cancer statistics, 2012. CA Cancer J. Clin., [s.l.], v. 65, n. 2, p. 87-108, 2015.

VELMURUGAN, B. et al. Prevention of N-methyl-N'-nitro-N-nitrosoguanidine and saturated sodium chloride-induced gastric carcinogenesis in Wistar rats by lycopene. Eur J Cancer Prev., [s.l.], v. 11, n. 1, p. 19-26, 2002.

VELMURUGAN, B.; MANI, A.; NAGINI, S. Combination of S-allylcysteine and lycopene induces apoptosis by modulating Bcl-2, Bax, Bim and caspases during experimental gastric carcinogenesis. Eur J Cancer Prev, [s.l.], v. 14, n. 4, p. 387-393, 2005.

WALISZEWSKI, K. N.; BLASCO, G. Propiedades nutraceúticas del licopeno. Salud pública Méx, [s.l.], v. 52, n. 3, p. 254-265, 2010.

WILD, C. P. et al. Cancer Prevention Europe. Mol Oncol., [s.l.], v. 13, n. 3, p. 528-534, 2019.

YE, M. et al. Lycopene inhibits the cell proliferation and invasion of human head and neck squamous cell carcinoma. Mol Med Rep, [s.l.], v. 14, n. 4, p. 2953-2958, 2016.

Downloads

Publicado

2022-07-01

Como Citar

Sousa, A. K. de, Magalhães, D. de A., Perfeito, M. L. G., & Sousa, S. G. (2022). Sinergismo do Licopeno e Outras Drogas Contra o Câncer: uma prospecção tecnológica. Cadernos De Prospecção, 15(3), 993–1006. https://doi.org/10.9771/cp.v15i3.42989

Edição

Seção

Prospecções Tecnológicas de Assuntos Específicos